Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ImmunityBio (IBRX) Treasury Shares (2016 - 2025)

ImmunityBio (IBRX) has disclosed Treasury Shares for 11 consecutive years, with $163800.0 as the latest value for Q4 2025.

  • Quarterly Treasury Shares changed 0.0% to $163800.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $163800.0 through Dec 2025, changed 0.0% year-over-year, with the annual reading at $163800.0 for FY2025, 0.0% changed from the prior year.
  • Treasury Shares for Q4 2025 was $163800.0 at ImmunityBio, roughly flat from $163800.0 in the prior quarter.
  • The five-year high for Treasury Shares was $9.2 million in Q1 2025, with the low at $163800.0 in Q1 2021.
  • Average Treasury Shares over 5 years is $1.6 million, with a median of $163800.0 recorded in 2021.
  • The sharpest move saw Treasury Shares crashed 97.5% in 2023, then soared 5535.45% in 2025.
  • Over 5 years, Treasury Shares stood at $163800.0 in 2021, then surged by 3899.63% to $6.6 million in 2022, then plummeted by 97.5% to $163800.0 in 2023, then changed by 0.0% to $163800.0 in 2024, then changed by 0.0% to $163800.0 in 2025.
  • According to Business Quant data, Treasury Shares over the past three periods came in at $163800.0, $163800.0, and $163800.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.